Target intelligence / Profile preview

Solute carrier family 44 member 1 (SLC44A1)

Target
SLC44A1
Molecular classification
Transporter, Solute carrier (SLC), Membrane protein, CD molecule
01

Overview

Solute carrier family 44 member 1 (SLC44A1), also known as choline transporter-like protein 1 (CTL1), is a membrane transporter responsible for the sodium-independent transmembrane uptake of choline and ethanolamine. It is expressed ubiquitously across human tissues—including plasma membranes and mitochondria—and is essential for metabolic pathways such as phosphatidylcholine, betaine, and acetylcholine synthesis. SLC44A1 function is critical for maintaining membrane lipid homeostasis, supporting the synthesis of neurotransmitters in neurons, and ensuring adequate choline supply during development, cell differentiation, H1 and rapid cell proliferation (e.g., in cancer). Inhibition of SLC44A1 with the compound hemicholinium-3 (HC-3) is used experimentally to block choline uptake. Genetic alterations—such as SLC44A1-PRKCA gene fusion in papillary glioneuronal tumor—and loss-of-function mutations have clinical consequence, linking SLC44A1 to roles in various diseases including cancers, neurodegenerative disorders, and metabolic or developmental syndromes[1][2][3][4].

Other names
Choline transporter-like protein 1CTL1CD92CDW92CHTL1CONATOCCDw92 antigen
02

Mechanism of action

Inhibition of choline uptake through competitive blockade of the transporter

03

Biological functions

Choline transportPhospholipid synthesisAcetylcholine synthesisBetaine synthesisEthanolamine transportMembrane lipid homeostasisRegulation of cellular metabolism
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseasePostural orthostatic tachycardia syndrome (POTS)Papillary glioneuronal tumorPlacental insufficiencyDevelopmental disorders
05

Safety considerations

Potential mitochondrial dysfunction and membrane homeostasis disturbance with inhibition or loss-of-functionpossible off-target effects due to broad tissue expression
06

Interacting drugs

Hemicholinium-3 (HC-3)
07

Biomarkers

SLC44A1-PRKCA fusion (papillary glioneuronal tumor)CTL1 protein expression (monocytic cell differentiation, certain cancers)SLC44A1 mutations/SNPs (diagnostic in neurodevelopmental disorders and cognition)

Beyond the preview

Go deeper on Solute carrier family 44 member 1 (SLC44A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 44 member 1 (SLC44A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call